By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

UCB Pharma 

Allée de la Recherche, 60

Brussels    1070  Belgium
Phone: 32-2-559-9264 Fax: 32-2-559-9571


SEARCH JOBS








Company News
BioTie Therapies Corp. To Regain Global Rights To Tozadenant From UCB Pharma (UCBJF.PK) 3/21/2014 9:02:37 AM
Nodality, Inc., UCB Pharma (UCBJF.PK) Strike Multi-Year Companion Diagnostic Pact 2/10/2012 8:53:47 AM
ALS Therapy Development Institute Announces Research Agreement with Biogen Idec, Inc. (Massachusetts) (BIIB) and UCB Pharma (UCBJF.PK) to Investigate the Role of CD40L in ALS 12/19/2011 10:38:14 AM
UCB Pharma (UCBJF.PK) To Test Arthritis Drug Cimzia Against Abbott Laboratories (ABT)'s Humira 5/26/2011 6:52:02 AM
UCB Pharma (UCBJF.PK) and PDL BioPharma, Inc. (PDLI) Resolve Patent Disputes; UCB to Pay PDL $10 Million 2/8/2011 7:09:58 AM
Transdermal Rotigotine Improves Quality of Life in Patients with Parkinson's Disease: Presented at WPC, UCB Pharma (UCBJF.PK) Study 10/6/2010 12:21:09 PM
Inaugural BIOTECanada-UCB Pharma (UCBJF.PK) National Health Innovation Patient Advocacy Awards Granted 9/25/2008 9:39:29 AM
Entelos, Inc. Enters Research Deal with UCB Pharma (UCBJF.PK) in Rheumatoid Arthritis 1/21/2008 8:05:36 AM
Mylan Laboratories Inc. (MYL) Settles Its First-to-File Opportunity on Levetiracetam with UCB Pharma (UCBJF.PK) 10/5/2007 9:46:18 AM
UCB Group (UCBJF.PK) And Sanofi-Aventis (France) (SASY.PA) Sign A Co-Promotion Agreement For Xyzal(R); In The United States 9/25/2006 4:44:18 PM
1234
//-->